These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6356131)

  • 1. Differential agglutination by soybean agglutinin of human leukemia and neuroblastoma cell lines: potential application to autologous bone marrow transplantation.
    Reisner Y
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6657-61. PubMed ID: 6356131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation.
    Reisner Y; Gan J
    Cancer Res; 1985 Sep; 45(9):4026-31. PubMed ID: 2411394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionation of feline bone marrow with the soybean agglutinin lectin yields populations enriched for erythroid and myeloid elements: transplantation of soybean agglutinin-negative cells into lethally irradiated recipients.
    Gengozian N; Reyes L; Pu R; Homer BL; Bova FJ; Yamamoto JK
    Transplantation; 1997 Aug; 64(3):510-8. PubMed ID: 9275120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin.
    Reisner Y; Kapoor N; Hodes MZ; O'Reilly RJ; Good RA
    Blood; 1982 Feb; 59(2):360-3. PubMed ID: 6799017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
    Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
    Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
    [No Abstract]   [Full Text] [Related]  

  • 6. Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.
    Verdonck LF; Dekker AW; van Heugten H; van Kempen ML; Punt K; de Gast GC
    Haematol Blood Transfus; 1987; 30():563-6. PubMed ID: 3305219
    [No Abstract]   [Full Text] [Related]  

  • 7. Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging.
    Mumcuoglu M; Favrot M; Slavin S
    Exp Hematol; 1990 Jan; 18(1):55-60. PubMed ID: 2298270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin.
    Ebell W; Castro-Malaspina H; Moore MA; O'Reilly RJ
    Blood; 1985 May; 65(5):1105-11. PubMed ID: 3888303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.
    Reisner Y; Itzicovitch L; Meshorer A; Sharon N
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2933-6. PubMed ID: 26916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment for GM-CFU from human bone marrow using Sambucus nigra agglutinin: potential application to bone marrow transplantation.
    Mumcuoglu M; Manor D; Slavin S
    Exp Hematol; 1986 Nov; 14(10):946-50. PubMed ID: 3533587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.
    Nagler A; Morecki S; Slavin S
    Mol Biotechnol; 1999 Apr; 11(2):181-94. PubMed ID: 10464772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin.
    Reisner Y; Kapoor N; O'Reilly RJ; Good RA
    Lancet; 1980 Dec 20-27; 2(8208-8209):1320-4. PubMed ID: 6109148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
    O'Reilly RJ; Keever C; Kernan NA; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):55-60. PubMed ID: 3321647
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.
    Keever CA; Welte K; Sullivan M; O'Reilly RJ
    Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
    Hervé P; Flesch M
    Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of lectin-binding cells using polystyrene culture devices with covalently immobilized soybean agglutinin.
    Schain LR; Okrongly D; Okarma TB; Lebkowski JS
    J Hematother; 1994; 3(1):37-46. PubMed ID: 7922007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow.
    Morecki S; Margel S; Slavin S
    Cancer Res; 1988 Aug; 48(16):4573-7. PubMed ID: 3396008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte reconstitution in children receiving soybean agglutinin T-depleted bone marrow transplants.
    Cowan MJ; McHugh T; Smith W; Wara D; Matthay K; Ablin A; Casavant C; Stites D
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2744. PubMed ID: 3274585
    [No Abstract]   [Full Text] [Related]  

  • 19. Haploidentical bone marrow transplantation using soybean agglutinin-processed, T-depleted marrow.
    Matthay K; Wara DW; Ablin AJ; Cowan MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2678-9. PubMed ID: 3274578
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationships between degree of binding, cytotoxicity and cytoagglutinating activity of plant-derived agglutinins in normal lymphocytes and cultured leukemic cell lines.
    Ohba H; Bakalova R
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):451-8. PubMed ID: 12695857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.